Abstract P174 – Table 1. Resolution of NPAEs after switch to DOR‐based regimen. | ||
---|---|---|
EVF/FTC/TDF | DRV/r + 2 NRTIs | |
Switched to DOR regimen at week 96 | 269 | 233 |
NPAE during DB phase (week 0‐96) | 155 (57.6%) | 41 (17.6%) |
NPAE ongoing at week 96 | 26 (9.7%) | 15 (6.4%) |
NPAE still ongoing at week 192 after switch to DOR | 7 (2.6%) | 9 (3.9%) |
New NPAE after switch to DOR (week 96‐192) | 25 (9.3%) | 18 (7.7%) |
New NPAE still ongoing at week 192 | 10 (3.7%) | 7 (3.0%) |